← back to search

Stephanie Haase

University Hospital Heidelberg · DE
Area of research
Radiology, Nuclear Medicine and Imaging · Immunology
Research interest
Research interests include Antibody, CD22, Conjugate, Antibody-drug conjugate, Drug, and Somatic hypermutation.
h-index
—
citations
40
works
2
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

A Humanized Anti-CD22-Onconase Antibody-Drug Conjugate Mediates Highly Potent Destruction of Targeted Tumor Cells
Journal of Immunology Research 2015cited by 26position: middledoi
Generation of “LYmph Node Derived Antibody Libraries” (LYNDAL) for selecting fully human antibody fragments with therapeutic potential
mAbs 2013cited by 14position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Tobias Weber · Technical University of Munich2 papers (2013–2015)Michaela A.E. Arndt · Heidelberg University2 papers (2013–2015)Dirk Jäger · German Cancer Research Center2 papers (2013–2015)Gerhard Moldenhauer · DKFZ-ZMBH Alliance1 papers (2013–2013)— · 1 papers (2013–2013)Jürgen Krauß · Ludwig-Maximilians-Universität München1 papers (2015–2015)P. Federspil · University Hospital Heidelberg1 papers (2013–2013)Tamana Karimi · University Hospital Heidelberg1 papers (2013–2013)Evelyn Exner · University Hospital Heidelberg1 papers (2015–2015)Athanasios Mavratzas · University of Mannheim1 papers (2015–2015)Anne Schlegelmilch · University Hospital Heidelberg1 papers (2013–2013)Roland E. Kontermann · Drexel University1 papers (2013–2013)Jürgen Krauß · Heidelberg University1 papers (2013–2013)Armin Keller · University Hospital Heidelberg1 papers (2013–2013)Ludger Große‐Hovest · University of Tübingen1 papers (2015–2015)Benedikt Bötticher · University Hospital Heidelberg1 papers (2015–2015)Stefan Kiesgen · University Hospital Heidelberg1 papers (2015–2015)Walter Mier · Heidelberg University1 papers (2015–2015)Jonathan D. Kiefer · University Hospital Heidelberg1 papers (2013–2013)Christel Herold‐Mende · German Cancer Research Center1 papers (2013–2013)